SWAP70 and metabolic dysfunction-associated steatotic liver disease: However, studies showed that SWAP70 is a protective molecule that can suppress the progression of nonalcoholic fatty liver disease by inhibiting hepatic steatosis and inflammation44 and Pathological Cardiac Hypertrophy,45 both of these pathological procedures were associated with stroke occurrence.